Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Artesunate × Clear all

Phase

Status

Unknown 2 Not yet recruiting 2 Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 1

Interventions

pembrolizumab 380 Carboplatin 269 Cyclophosphamide 265 Nivolumab 258 Specimen Handling 215 Paclitaxel 214 Magnetic Resonance Spectroscopy 212 Cisplatin 206 Radiotherapy 191 Dexamethasone 161 Gemcitabine 156 durvalumab 154 Biopsy 148 atezolizumab 137 Lenalidomide 127 Doxorubicin 119 Rituximab 118 Bevacizumab 118 Docetaxel 116 Ipilimumab 114 Capecitabine 104 Oxaliplatin 103 Radiosurgery 101 Radiation 100 Fluorouracil 99 fludarabine 98 Etoposide 95 venetoclax 94 Prednisone 93 Pemetrexed 90

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05555862 2025-05-18

anal HSIL HIV-

Frantz Viral Therapeutics, LLC

Phase 2 Active not recruiting

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡